Venus Medtech (Hangzhou) Statistics

Total Valuation

HKG:2500 has a market cap or net worth of HKD 1.06 billion. The enterprise value is 1.13 billion.

Market Cap	1.06B
Enterprise Value	1.13B

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2500 has 441.01 million shares outstanding.

Current Share Class	441.01M
Shares Outstanding	441.01M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.55%
Owned by Institutions (%)	16.19%
Float	292.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.11
PB Ratio	0.45
P/TBV Ratio	1.36
P/FCF Ratio	n/a
P/OCF Ratio	41.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.48
EV / Sales	2.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-103.96

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.17.

Current Ratio	2.22
Quick Ratio	1.85
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-36.27
Interest Coverage	-23.19

Financial Efficiency

Return on equity (ROE) is -27.97% and return on invested capital (ROIC) is -7.63%.

Return on Equity (ROE)	-27.97%
Return on Assets (ROA)	-6.30%
Return on Invested Capital (ROIC)	-7.63%
Return on Capital Employed (ROCE)	-13.36%
Revenue Per Employee	725,105
Profits Per Employee	-1.10M
Employee Count	691
Asset Turnover	0.12
Inventory Turnover	0.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.74% in the last 52 weeks. The beta is 0.84, so HKG:2500's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-57.74%
50-Day Moving Average	5.04
200-Day Moving Average	7.27
Relative Strength Index (RSI)	64.93
Average Volume (20 Days)	755,475

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2500 had revenue of HKD 501.05 million and -760.15 million in losses. Loss per share was -1.74.

Revenue	501.05M
Gross Profit	391.35M
Operating Income	-410.74M
Pretax Income	-788.25M
Net Income	-760.15M
EBITDA	-378.93M
EBIT	-410.74M
Loss Per Share	-1.74

Full Income Statement

Balance Sheet

The company has 325.32 million in cash and 392.77 million in debt, giving a net cash position of -67.45 million or -0.15 per share.

Cash & Cash Equivalents	325.32M
Total Debt	392.77M
Net Cash	-67.45M
Net Cash Per Share	-0.15
Equity (Book Value)	2.35B
Book Value Per Share	5.37
Working Capital	469.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.26 million and capital expenditures -36.09 million, giving a free cash flow of -10.83 million.

Operating Cash Flow	25.26M
Capital Expenditures	-36.09M
Free Cash Flow	-10.83M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 78.11%, with operating and profit margins of -81.98% and -151.71%.

Gross Margin	78.11%
Operating Margin	-81.98%
Pretax Margin	-157.32%
Profit Margin	-151.71%
EBITDA Margin	-75.63%
EBIT Margin	-81.98%
FCF Margin	n/a

Dividends & Yields

HKG:2500 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-71.82%
FCF Yield	-1.02%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2500 has an Altman Z-Score of -1.63. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.63
Piotroski F-Score	n/a